3Dbiology_Banner

Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology

NanoString sat down with McGarry Houghton, M.D., Associate Member of the Clinical Research and Human Biology Divisions at Fred Hutch Cancer Research Center, to discuss how his lab is using 3D Biology™ Technology to advance understanding of the lung tumor...

/ June 1, 2017
3Dbiology_Banner

Researcher Profiles: How NanoString® Grant Program Winners are Utilizing 3D Biology™ Technology

This past February, four grant program applicants were awarded nCounter Vantage 3D™ Assays of their choice to profile 36 samples. NanoString followed up with each of the winners to explore how they intend to use the assays to advance their...

/ May 8, 2017
DSP_Backdrop_v1F_wLabels

Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies

Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The molecular underpinnings of toxicities from immune checkpoint inhibitors are not...

/ March 31, 2017
3Dbiology_Banner

Monitoring Clinically Actionable Proteins- A Q&A with Gordon Mills, MD Anderson Cancer Center

NanoString sat down with Gordon Mills, M.D., Ph.D., Chair of Systems Biology Department at MD Anderson Cancer Center in Houston and lead developer of The Cancer Proteome Atlas (TCPA), to talk about the value of cataloging proteins and the future...

/ March 20, 2017
Progression_Final_webBanner

The IO Revolution, Part 3 of 4: The Role of the Tumor in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. Part two further examined the role of the host, and in this blog, we consider the role of the tumor in the...

/ March 9, 2017